US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NanoViricides

1.43

+0.03002.14%

Volume:288.17K

Turnover:423.41K

Market Cap:36.46M

PE:-3.51

High:1.50

Open:1.44

Low:1.40

Close:1.40

52wk High:2.23

52wk Low:0.8500

Shares:25.50M

Float Shares:24.90M

Volume Ratio:0.92

T/O Rate:1.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4071

EPS(LYR):-0.4071

ROE:-101.46%

ROA:-55.53%

PB:4.20

PE(LYR):-3.51

Loading ...

Overview Company News Filings

NanoViricides to Present at NIBA 153rd Investment Conference

NanoViricides says Phase II trial of NV-387 in ebola ‘proceeding as designed’

NanoViricides Begins Phase II Trial of NV-387 Oral Gummies for Bundibugyo Ebola in DRC

NanoViricides Sets President Anil Diwan Base Salary at $400,000 Under Extension Agreement

NanoViricides ‘actively exploring’ additional required funding

NanoViricides reports FY26 EPS (41c) vs. (63c) last year

Nanoviricides Q4 EPS $(0.10), Inline

Benzinga Earnings

NanoViricides FY26 Net Loss Narrows 13% to $8.22 Million; Revenue Remains no Revenue

NanoViricides Starts Phase II DRC Trial of Oral NV-387 Gummies in Bundibugyo Ebola Patients

Analysts Offer Insights on Healthcare Companies: NanoViricides (NNVC) and Ionis Pharmaceuticals (IONS)

NanoViricides begins Phase II trial of NV-387 in Monkeypox in DRC

NanoViricides Begins Phase II Trial of NV-387 Oral Gummies for Mpox in Congo

NanoViricides Wins DRC Regulatory Clearance to Start Phase II NV-387 Ebola Trial

NanoViricides provides updateon Measles Drug Treatment Program

NanoViricides Drafts Phase II Trial Protocol for NV-387 Measles Treatment

NanoViricides registers to sell 2.52M shares of common stock for holders

NanoViricides to begin Phase II trial of NV-387 in ebola ‘soon’

NanoViricides Wins DRC Acorep Clearance for Phase II NV-387 Ebola Treatment Trial

NanoViricides, Inc: Received Regulatory Approval for a Phase Ii Clinical Trial of Nv-387 Oral Gummies as a Treatment for Ebola in DR Congo

THOMSON REUTERS

NanoViricides Wins DRC Approval for Phase II Trial of NV-387 Oral Gummies for Ebola Treatment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/NNVC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NNVC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NNVC\",,,,,undefined,":{"symbol":"NNVC","market":"US","secType":"STK","nameCN":"NanoViricides","latestPrice":1.43,"timestamp":1791399254921,"preClose":1.4,"halted":0,"volume":288167,"delay":0,"changeRate":0.02142857142857145,"floatShares":24898700,"shares":25499200,"eps":-0.407103,"marketStatus":"Trading","change":0.03,"latestTime":"10-07 14:55:56 EDT","open":1.44,"high":1.5,"low":1.4001,"amount":423408.2685052,"amplitude":0.071357,"askPrice":1.47,"askSize":528,"bidPrice":1.4,"bidSize":716,"shortable":3,"etf":0,"ttmEps":-0.407103,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791403200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1380081600000,"exchange":"AMEX","adjPreClose":1.4,"preHourTrading":{"tag":"盘前","latestPrice":1.41,"preClose":1.4,"latestTime":"09:09 EDT","volume":8288,"amount":11730.0693888,"timestamp":1791378599605,"change":0.01,"changeRate":0.007143,"amplitude":0.04},"postHourTrading":{"tag":"盘后","latestPrice":1.37,"preClose":1.4,"latestTime":"19:37 EDT","volume":2004,"amount":2800.8125,"timestamp":1791329831862,"change":-0.03,"changeRate":-0.021429,"amplitude":0.048357},"volumeRatio":0.915288,"impliedVol":1.1767,"impliedVolPercentile":0.502},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NNVC\",,,,,undefined,":{"symbol":"NNVC","floatShares":24898700,"roa":"-55.53%","roe":"-101.46%","lyrEps":-0.407103,"volumeRatio":0.915288,"shares":25499200,"dividePrice":0,"high":1.5,"amplitude":0.071357,"preClose":1.4,"low":1.4001,"week52Low":0.85,"pbRate":"4.20","week52High":2.2299,"institutionHeld":0,"latestPrice":1.43,"committee":0.151125,"eps":-0.407103,"divideRate":0,"volume":288167,"delay":0,"ttmEps":-0.407103,"open":1.44,"prevYearClose":1.13,"prevWeekClose":1.28,"prevMonthClose":1.3,"prevQuarterClose":1.3,"fiveDayClose":1.3,"twentyDayClose":1.04,"sixtyDayClose":1.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NNVC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-09-29","symbol":"NNVC","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1759118400000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2025-05-15","symbol":"NNVC","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2025-02-14","symbol":"NNVC","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1739509200000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2024-11-14","symbol":"NNVC","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.23},{"market":"US","date":"2024-09-27","symbol":"NNVC","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1727409600000,"reportTimeType":"post","actualEps":-0.19}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NNVC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NNVC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1783396800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NNVC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NNVC","date":"2026-10-06","current":-3.438933,"percent":0.068482,"low":-7.139617,"twenty":-3.052682,"median":-2.395993,"eighty":-2.019648,"high":-1.333135,"avg":-2.671283,"sd":1.02764,"marketCap":37011250},"quantilePoints":[{"date":"2021-10-08","current":-5.829949,"twenty":-8.016857,"median":-4.527335,"eighty":-2.509122,"marketCap":50276850},{"date":"2021-10-15","current":-6.36953,"twenty":-8.010675,"median":-4.527335,"eighty":-2.509122,"marketCap":56193200},{"date":"2021-10-22","current":-6.304269,"twenty":-7.953732,"median":-4.527335,"eighty":-2.509122,"marketCap":55617450},{"date":"2021-10-29","current":-6.186798,"twenty":-7.94329,"median":-4.527335,"eighty":-2.509122,"marketCap":54581100},{"date":"2021-11-05","current":-6.173746,"twenty":-7.890607,"median":-4.527335,"eighty":-2.509122,"marketCap":54465950},{"date":"2021-11-12","current":-6.095432,"twenty":-7.788302,"median":-4.527335,"eighty":-2.509122,"marketCap":53775050},{"date":"2021-11-19","current":-5.797853,"twenty":-7.663997,"median":-4.527335,"eighty":-2.509122,"marketCap":52899750},{"date":"2021-11-26","current":-6.138903,"twenty":-7.585674,"median":-4.527335,"eighty":-2.509122,"marketCap":56011500},{"date":"2021-12-03","current":-5.633644,"twenty":-7.428051,"median":-4.527335,"eighty":-2.509122,"marketCap":51401500},{"date":"2021-12-10","current":-5.406277,"twenty":-7.300703,"median":-4.527335,"eighty":-2.509122,"marketCap":49327000},{"date":"2021-12-17","current":-5.229436,"twenty":-7.180968,"median":-4.527335,"eighty":-2.509122,"marketCap":47713500},{"date":"2021-12-23","current":-4.976806,"twenty":-7.079181,"median":-4.527335,"eighty":-2.509122,"marketCap":45408500},{"date":"2021-12-31","current":-4.698914,"twenty":-6.987904,"median":-4.527335,"eighty":-2.509122,"marketCap":42873000},{"date":"2022-01-07","current":-3.890498,"twenty":-6.926651,"median":-4.436412,"eighty":-2.509122,"marketCap":35497000},{"date":"2022-01-14","current":-3.675763,"twenty":-6.89782,"median":-4.401483,"eighty":-2.509122,"marketCap":33537750},{"date":"2022-01-21","current":-2.905242,"twenty":-6.846702,"median":-4.310739,"eighty":-2.509122,"marketCap":26507500},{"date":"2022-01-28","current":-2.728401,"twenty":-6.779582,"median":-4.173405,"eighty":-2.509122,"marketCap":24894000},{"date":"2022-02-04","current":-3.05682,"twenty":-6.712109,"median":-4.02803,"eighty":-2.509122,"marketCap":27890500},{"date":"2022-02-11","current":-2.854716,"twenty":-6.637806,"median":-3.995999,"eighty":-2.509122,"marketCap":26046500},{"date":"2022-02-18","current":-2.62043,"twenty":-6.580578,"median":-3.946834,"eighty":-2.509122,"marketCap":22837320},{"date":"2022-02-25","current":-2.646899,"twenty":-6.52606,"median":-3.923893,"eighty":-2.509122,"marketCap":23068000},{"date":"2022-03-04","current":-2.50132,"twenty":-6.496806,"median":-3.868397,"eighty":-2.507562,"marketCap":21799260},{"date":"2022-03-11","current":-2.448382,"twenty":-6.462701,"median":-3.821268,"eighty":-2.492597,"marketCap":21337900},{"date":"2022-03-18","current":-2.964527,"twenty":-6.435992,"median":-3.787617,"eighty":-2.484025,"marketCap":25836160},{"date":"2022-03-25","current":-3.096872,"twenty":-6.399341,"median":-3.766488,"eighty":-2.484025,"marketCap":26989560},{"date":"2022-04-01","current":-2.73954,"twenty":-6.395635,"median":-3.735019,"eighty":-2.484025,"marketCap":23875380},{"date":"2022-04-08","current":-2.593961,"twenty":-6.356646,"median":-3.703835,"eighty":-2.484025,"marketCap":22606640},{"date":"2022-04-14","current":-2.501584,"twenty":-6.335311,"median":-3.656716,"eighty":-2.482663,"marketCap":21801566},{"date":"2022-04-22","current":-2.223395,"twenty":-6.304269,"median":-3.638432,"eighty":-2.478152,"marketCap":19377120},{"date":"2022-04-29","current":-1.97194,"twenty":-6.279718,"median":-3.579246,"eighty":-2.47116,"marketCap":17185660},{"date":"2022-05-06","current":-1.97194,"twenty":-6.219501,"median":-3.523708,"eighty":-2.460477,"marketCap":17185660},{"date":"2022-05-13","current":-1.710426,"twenty":-6.176384,"median":-3.477537,"eighty":-2.45259,"marketCap":14906541},{"date":"2022-05-20","current":-3.57635,"twenty":-6.112925,"median":-3.448283,"eighty":-2.44683,"marketCap":30040400},{"date":"2022-05-27","current":-2.957366,"twenty":-6.0948,"median":-3.404402,"eighty":-2.44683,"marketCap":24841100},{"date":"2022-06-03","current":-2.751038,"twenty":-6.063146,"median":-3.382022,"eighty":-2.44683,"marketCap":23108000},{"date":"2022-06-10","current":-2.778549,"twenty":-6.021887,"median":-3.36235,"eighty":-2.44683,"marketCap":23339080},{"date":"2022-06-17","current":-2.764793,"twenty":-5.978029,"median":-3.327968,"eighty":-2.44683,"marketCap":23223540},{"date":"2022-06-24","current":-2.806059,"twenty":-5.953332,"median":-3.30945,"eighty":-2.445278,"marketCap":23570160},{"date":"2022-07-01","current":-2.599731,"twenty":-5.898451,"median":-3.23985,"eighty":-2.445278,"marketCap":21837060},{"date":"2022-07-08","current":-3.148563,"twenty":-5.871439,"median":-3.219656,"eighty":-2.445278,"marketCap":26447106},{"date":"2022-07-15","current":-2.737283,"twenty":-5.837732,"median":-3.192745,"eighty":-2.445278,"marketCap":22992460},{"date":"2022-07-22","current":-2.874835,"twenty":-5.807263,"median":-3.167389,"eighty":-2.445278,"marketCap":24147860},{"date":"2022-07-29","current":-2.503445,"twenty":-5.78537,"median":-3.144776,"eighty":-2.440257,"marketCap":21028280},{"date":"2022-08-05","current":-4.869338,"twenty":-5.744619,"median":-3.132647,"eighty":-2.440257,"marketCap":40901160},{"date":"2022-08-12","current":-3.823943,"twenty":-5.727928,"median":-3.132647,"eighty":-2.440257,"marketCap":32120120},{"date":"2022-08-19","current":-3.342511,"twenty":-5.684312,"median":-3.132647,"eighty":-2.440257,"marketCap":28076220},{"date":"2022-08-26","current":-3.094918,"twenty":-5.661854,"median":-3.132245,"eighty":-2.440257,"marketCap":25996500},{"date":"2022-09-02","current":-2.902345,"twenty":-5.581809,"median":-3.128118,"eighty":-2.440257,"marketCap":24378940},{"date":"2022-09-09","current":-2.984876,"twenty":-5.560806,"median":-3.117013,"eighty":-2.440257,"marketCap":25072180},{"date":"2022-09-16","current":-2.668507,"twenty":-5.55316,"median":-3.10436,"eighty":-2.440257,"marketCap":22414760},{"date":"2022-09-23","current":-2.14581,"twenty":-5.519162,"median":-3.095823,"eighty":-2.439684,"marketCap":18024240},{"date":"2022-09-30","current":-2.379648,"twenty":-5.477266,"median":-3.088522,"eighty":-2.439647,"marketCap":19988420},{"date":"2022-10-07","current":-2.132055,"twenty":-5.456405,"median":-3.080603,"eighty":-2.439647,"marketCap":17908700},{"date":"2022-10-14","current":-2.502362,"twenty":-5.43594,"median":-3.072683,"eighty":-2.437394,"marketCap":20286302},{"date":"2022-10-21","current":-2.402267,"twenty":-5.421719,"median":-3.06696,"eighty":-2.434784,"marketCap":19474850},{"date":"2022-10-28","current":-2.359369,"twenty":-5.377446,"median":-3.06013,"eighty":-2.430342,"marketCap":19127085},{"date":"2022-11-04","current":-2.334363,"twenty":-5.363019,"median":-3.057014,"eighty":-2.4206,"marketCap":18924360},{"date":"2022-11-11","current":-2.477575,"twenty":-5.336338,"median":-3.043934,"eighty":-2.417533,"marketCap":20085364},{"date":"2022-11-18","current":-2.711681,"twenty":-5.332826,"median":-3.036058,"eighty":-2.417533,"marketCap":19156500},{"date":"2022-11-25","current":-2.760984,"twenty":-5.332826,"median":-3.034986,"eighty":-2.417533,"marketCap":19504800},{"date":"2022-12-02","current":-2.777419,"twenty":-5.332826,"median":-3.028333,"eighty":-2.417533,"marketCap":19620900},{"date":"2022-12-09","current":-2.39121,"twenty":-5.292381,"median":-3.026142,"eighty":-2.416192,"marketCap":16892550},{"date":"2022-12-16","current":-2.087173,"twenty":-5.292381,"median":-3.018926,"eighty":-2.406742,"marketCap":14744700},{"date":"2022-12-23","current":-1.972132,"twenty":-5.292381,"median":-3.00582,"eighty":-2.395506,"marketCap":13932000},{"date":"2022-12-30","current":-1.824222,"twenty":-5.292381,"median":-2.997432,"eighty":-2.389879,"marketCap":12887100},{"date":"2023-01-06","current":-2.202214,"twenty":-5.277173,"median":-2.989706,"eighty":-2.387968,"marketCap":15557400},{"date":"2023-01-13","current":-2.333853,"twenty":-5.260084,"median":-2.981981,"eighty":-2.376115,"marketCap":16487361},{"date":"2023-01-20","current":-2.30082,"twenty":-5.250996,"median":-2.973783,"eighty":-2.373517,"marketCap":16254000},{"date":"2023-01-27","current":-2.399427,"twenty":-5.240028,"median":-2.96653,"eighty":-2.370947,"marketCap":16950600},{"date":"2023-02-03","current":-2.284386,"twenty":-5.221675,"median":-2.956693,"eighty":-2.366583,"marketCap":16137900},{"date":"2023-02-10","current":-2.276169,"twenty":-5.202929,"median":-2.950137,"eighty":-2.360695,"marketCap":16079850},{"date":"2023-02-17","current":-2.44914,"twenty":-5.171998,"median":-2.943354,"eighty":-2.359369,"marketCap":16870750},{"date":"2023-02-24","current":-2.128219,"twenty":-5.154465,"median":-2.937326,"eighty":-2.348627,"marketCap":14660100},{"date":"2023-03-03","current":-2.330906,"twenty":-5.122989,"median":-2.92765,"eighty":-2.343232,"marketCap":16056300},{"date":"2023-03-10","current":-2.145109,"twenty":-5.087088,"median":-2.913716,"eighty":-2.342061,"marketCap":14776450},{"date":"2023-03-17","current":-2.195781,"twenty":-5.05618,"median":-2.905242,"eighty":-2.334159,"marketCap":15125500},{"date":"2023-03-24","current":-2.094437,"twenty":-5.017952,"median":-2.902345,"eighty":-2.329408,"marketCap":14427400},{"date":"2023-03-31","current":-1.97975,"twenty":-5.017055,"median":-2.891819,"eighty":-2.325041,"marketCap":13637383},{"date":"2023-04-06","current":-2.753172,"twenty":-5.017055,"median":-2.888698,"eighty":-2.322276,"marketCap":18965050},{"date":"2023-04-14","current":-1.993094,"twenty":-5.017952,"median":-2.874835,"eighty":-2.316037,"marketCap":13729300},{"date":"2023-04-21","current":-2.263344,"twenty":-5.002368,"median":-2.859591,"eighty":-2.313801,"marketCap":15590900},{"date":"2023-04-28","current":-2.280234,"twenty":-5.002368,"median":-2.849614,"eighty":-2.312786,"marketCap":15707250},{"date":"2023-05-05","current":-2.077547,"twenty":-5.002368,"median":-2.840873,"eighty":-2.302937,"marketCap":14311050},{"date":"2023-05-11","current":-2.043766,"twenty":-5.002368,"median":-2.835777,"eighty":-2.30082,"marketCap":14078350},{"date":"2023-05-19","current":-1.920317,"twenty":-5.002518,"median":-2.832097,"eighty":-2.294808,"marketCap":13055420},{"date":"2023-05-26","current":-1.887542,"twenty":-5.002667,"median":-2.817128,"eighty":-2.284962,"marketCap":12832600},{"date":"2023-06-02","current":-2.239311,"twenty":-5.002667,"median":-2.810544,"eighty":-2.283362,"marketCap":15224130},{"date":"2023-06-09","current":-1.973339,"twenty":-5.002817,"median":-2.806059,"eighty":-2.276679,"marketCap":13415900},{"date":"2023-06-16","current":-1.870383,"twenty":-5.008153,"median":-2.792391,"eighty":-2.269675,"marketCap":12715940},{"date":"2023-06-23","current":-1.921861,"twenty":-5.010821,"median":-2.779567,"eighty":-2.263344,"marketCap":13065920},{"date":"2023-06-30","current":-2.144934,"twenty":-5.017055,"median":-2.778549,"eighty":-2.263295,"marketCap":14582500},{"date":"2023-07-06","current":-2.024818,"twenty":-5.017952,"median":-2.777419,"eighty":-2.259272,"marketCap":13765880},{"date":"2023-07-14","current":-2.488124,"twenty":-5.020645,"median":-2.769833,"eighty":-2.254292,"marketCap":16915700},{"date":"2023-07-21","current":-2.745516,"twenty":-5.0361,"median":-2.767019,"eighty":-2.252684,"marketCap":18665600},{"date":"2023-07-27","current":-2.676878,"twenty":-5.039964,"median":-2.764793,"eighty":-2.252282,"marketCap":18198960},{"date":"2023-08-04","current":-2.453805,"twenty":-5.039964,"median":-2.753964,"eighty":-2.252129,"marketCap":16682380},{"date":"2023-08-11","current":-2.219738,"twenty":-5.039964,"median":-2.751307,"eighty":-2.246058,"marketCap":15091061},{"date":"2023-08-18","current":-2.21991,"twenty":-5.039964,"median":-2.751307,"eighty":-2.244476,"marketCap":15092230},{"date":"2023-08-25","current":-2.667127,"twenty":-5.039964,"median":-2.753168,"eighty":-2.251186,"marketCap":18132670},{"date":"2023-09-01","current":-2.495054,"twenty":-5.039964,"median":-2.751038,"eighty":-2.251186,"marketCap":16962820},{"date":"2023-09-08","current":-2.340189,"twenty":-5.039964,"median":-2.74376,"eighty":-2.251186,"marketCap":15909955},{"date":"2023-09-15","current":-2.288567,"twenty":-5.039964,"median":-2.738088,"eighty":-2.246453,"marketCap":15559001},{"date":"2023-09-22","current":-2.185324,"twenty":-5.039964,"median":-2.725967,"eighty":-2.236945,"marketCap":14857091},{"date":"2023-09-29","current":-2.426225,"twenty":-5.039964,"median":-2.723609,"eighty":-2.236573,"marketCap":16494880},{"date":"2023-10-06","current":-2.254153,"twenty":-5.039964,"median":-2.723609,"eighty":-2.234464,"marketCap":15325031},{"date":"2023-10-13","current":-2.013251,"twenty":-5.039964,"median":-2.723467,"eighty":-2.230216,"marketCap":13687241},{"date":"2023-10-20","current":-1.572776,"twenty":-5.039964,"median":-2.723467,"eighty":-2.222732,"marketCap":13507900},{"date":"2023-10-27","current":-1.600128,"twenty":-5.039964,"median":-2.72369,"eighty":-2.219772,"marketCap":13742820},{"date":"2023-11-03","current":-1.5591,"twenty":-5.039964,"median":-2.72369,"eighty":-2.211571,"marketCap":13390440},{"date":"2023-11-10","current":-1.463365,"twenty":-5.039964,"median":-2.718749,"eighty":-2.202243,"marketCap":12568220},{"date":"2023-11-17","current":-1.487026,"twenty":-5.039964,"median":-2.715489,"eighty":-2.195907,"marketCap":13363424},{"date":"2023-11-24","current":-1.359275,"twenty":-5.039964,"median":-2.713071,"eighty":-2.189723,"marketCap":12215368},{"date":"2023-12-01","current":-1.503045,"twenty":-5.039964,"median":-2.709773,"eighty":-2.185324,"marketCap":13507379},{"date":"2023-12-08","current":-1.50958,"twenty":-5.039964,"median":-2.70214,"eighty":-2.168223,"marketCap":13566106},{"date":"2023-12-15","current":-1.489975,"twenty":-5.039964,"median":-2.696474,"eighty":-2.162,"marketCap":13389923},{"date":"2023-12-22","current":-1.385415,"twenty":-5.039964,"median":-2.696474,"eighty":-2.156514,"marketCap":12450279},{"date":"2023-12-29","current":-1.398485,"twenty":-5.039964,"median":-2.696931,"eighty":-2.156278,"marketCap":12567735},{"date":"2024-01-05","current":-1.424625,"twenty":-5.039964,"median":-2.698293,"eighty":-2.150909,"marketCap":12802646},{"date":"2024-01-12","current":-1.353525,"twenty":-5.039964,"median":-2.698293,"eighty":-2.145109,"marketCap":12163688},{"date":"2024-01-19","current":-1.359275,"twenty":-5.043083,"median":-2.699655,"eighty":-2.135592,"marketCap":12215368},{"date":"2024-01-26","current":-1.385415,"twenty":-5.039964,"median":-2.698293,"eighty":-2.120042,"marketCap":12450279},{"date":"2024-02-02","current":-1.476905,"twenty":-5.039964,"median":-2.698293,"eighty":-2.111328,"marketCap":13272468},{"date":"2024-02-09","current":-1.516115,"twenty":-5.039964,"median":-2.687524,"eighty":-2.094437,"marketCap":13624834},{"date":"2024-02-16","current":-1.498107,"twenty":-5.039964,"median":-2.682084,"eighty":-2.081184,"marketCap":14017010},{"date":"2024-02-23","current":-1.59882,"twenty":-5.039964,"median":-2.676392,"eighty":-2.064581,"marketCap":14959330},{"date":"2024-03-01","current":-1.699533,"twenty":-5.0361,"median":-2.668507,"eighty":-2.049674,"marketCap":15901650},{"date":"2024-03-08","current":-1.422572,"twenty":-5.0361,"median":-2.666881,"eighty":-2.03312,"marketCap":13310270},{"date":"2024-03-15","current":-1.472929,"twenty":-5.0361,"median":-2.656354,"eighty":-2.014962,"marketCap":13781430},{"date":"2024-03-22","current":-1.435162,"twenty":-5.0361,"median":-2.651857,"eighty":-1.997134,"marketCap":13428060},{"date":"2024-03-28","current":-1.422572,"twenty":-5.0361,"median":-2.646899,"eighty":-1.988953,"marketCap":13310270},{"date":"2024-04-05","current":-1.724712,"twenty":-5.039964,"median":-2.645782,"eighty":-1.976203,"marketCap":16137230},{"date":"2024-04-12","current":-1.59882,"twenty":-5.039964,"median":-2.640997,"eighty":-1.967997,"marketCap":14959330},{"date":"2024-04-19","current":-1.479223,"twenty":-5.039964,"median":-2.636576,"eighty":-1.942422,"marketCap":13840325},{"date":"2024-04-26","current":-1.397394,"twenty":-5.0361,"median":-2.625126,"eighty":-1.921861,"marketCap":13074690},{"date":"2024-05-03","current":-1.510696,"twenty":-5.0361,"median":-2.62043,"eighty":-1.908491,"marketCap":14134800},{"date":"2024-05-10","current":-2.303812,"twenty":-5.0361,"median":-2.62043,"eighty":-1.904702,"marketCap":21555570},{"date":"2024-05-17","current":-2.762595,"twenty":-5.0361,"median":-2.63632,"eighty":-1.904702,"marketCap":26267170},{"date":"2024-05-24","current":-2.762595,"twenty":-5.0361,"median":-2.640997,"eighty":-1.904702,"marketCap":26267170},{"date":"2024-05-31","current":-3.010361,"twenty":-5.0361,"median":-2.645943,"eighty":-1.904702,"marketCap":28622970},{"date":"2024-06-07","current":-3.282904,"twenty":-5.0361,"median":-2.651857,"eighty":-1.904702,"marketCap":31214350},{"date":"2024-06-14","current":-3.205683,"twenty":-5.039964,"median":-2.663299,"eighty":-1.904702,"marketCap":30480120},{"date":"2024-06-21","current":-2.522301,"twenty":-5.039964,"median":-2.666881,"eighty":-1.904582,"marketCap":23982420},{"date":"2024-06-28","current":-2.149547,"twenty":-5.039964,"median":-2.667004,"eighty":-1.904221,"marketCap":20438220},{"date":"2024-07-05","current":-2.186822,"twenty":-5.039964,"median":-2.667004,"eighty":-1.904221,"marketCap":20792640},{"date":"2024-07-12","current":-2.236523,"twenty":-5.039964,"median":-2.667004,"eighty":-1.904221,"marketCap":21265200},{"date":"2024-07-15","current":-2.161972,"twenty":-5.039964,"median":-2.667004,"eighty":-1.904221,"marketCap":20556360},{"date":"2024-08-02","current":-2.609277,"twenty":-5.05618,"median":-2.674394,"eighty":-1.887542,"marketCap":24809400},{"date":"2024-08-09","current":-2.360774,"twenty":-5.05618,"median":-2.674394,"eighty":-1.887542,"marketCap":22446600},{"date":"2024-08-16","current":-2.360774,"twenty":-5.05618,"median":-2.674394,"eighty":-1.887542,"marketCap":22446600},{"date":"2024-08-23","current":-2.286223,"twenty":-5.05618,"median":-2.675731,"eighty":-1.887542,"marketCap":21737760},{"date":"2024-08-30","current":-2.335924,"twenty":-5.05618,"median":-2.675731,"eighty":-1.890067,"marketCap":22210320},{"date":"2024-09-06","current":-2.224098,"twenty":-5.05618,"median":-2.675731,"eighty":-1.890067,"marketCap":21147060},{"date":"2024-09-13","current":-2.087421,"twenty":-5.05618,"median":-2.675731,"eighty":-1.899521,"marketCap":19847520},{"date":"2024-09-20","current":-1.96317,"twenty":-5.05618,"median":-2.675731,"eighty":-1.917578,"marketCap":18666120},{"date":"2024-09-27","current":-1.764368,"twenty":-5.05618,"median":-2.675731,"eighty":-1.921243,"marketCap":16775880},{"date":"2024-10-04","current":-2.008373,"twenty":-5.05618,"median":-2.675731,"eighty":-1.947416,"marketCap":16657740},{"date":"2024-10-11","current":-1.951398,"twenty":-5.05618,"median":-2.675731,"eighty":-1.961627,"marketCap":16185180},{"date":"2024-10-18","current":-2.122323,"twenty":-5.05618,"median":-2.675731,"eighty":-1.972856,"marketCap":17602860},{"date":"2024-10-25","current":-2.122323,"twenty":-5.05618,"median":-2.675731,"eighty":-1.978331,"marketCap":17602860},{"date":"2024-10-31","current":-1.937154,"twenty":-5.05618,"median":-2.675731,"eighty":-1.988348,"marketCap":16067040},{"date":"2024-11-08","current":-2.122323,"twenty":-5.05618,"median":-2.675818,"eighty":-2.003331,"marketCap":17602860},{"date":"2024-11-15","current":-1.908667,"twenty":-5.05618,"median":-2.675818,"eighty":-2.007658,"marketCap":15830760},{"date":"2024-11-22","current":-1.599829,"twenty":-5.05618,"median":-2.675818,"eighty":-2.007658,"marketCap":15121920},{"date":"2024-11-29","current":-2.06427,"twenty":-5.05618,"median":-2.675818,"eighty":-2.022617,"marketCap":19511920},{"date":"2024-12-06","current":-2.216055,"twenty":-5.05618,"median":-2.675818,"eighty":-2.028308,"marketCap":20946620},{"date":"2024-12-13","current":-2.231234,"twenty":-5.05618,"median":-2.675818,"eighty":-2.043766,"marketCap":21090090},{"date":"2024-12-20","current":-2.200877,"twenty":-5.05618,"median":-2.675818,"eighty":-2.051201,"marketCap":20803150},{"date":"2024-12-27","current":-2.291947,"twenty":-5.05618,"median":-2.675818,"eighty":-2.063251,"marketCap":21663970},{"date":"2025-01-03","current":-2.155341,"twenty":-5.05618,"median":-2.675818,"eighty":-2.067504,"marketCap":20372740},{"date":"2025-01-10","current":-2.109806,"twenty":-5.05618,"median":-2.675905,"eighty":-2.079813,"marketCap":19942330},{"date":"2025-01-17","current":-1.821415,"twenty":-5.05618,"median":-2.675905,"eighty":-2.079813,"marketCap":17216400},{"date":"2025-01-24","current":-1.699987,"twenty":-5.05618,"median":-2.675731,"eighty":-2.077956,"marketCap":16068640},{"date":"2025-01-31","current":-1.624095,"twenty":-5.019747,"median":-2.668507,"eighty":-2.064332,"marketCap":15351290},{"date":"2025-02-07","current":-1.86695,"twenty":-4.974978,"median":-2.666881,"eighty":-2.051347,"marketCap":17646810},{"date":"2025-02-14","current":-1.958021,"twenty":-4.948211,"median":-2.651857,"eighty":-2.049178,"marketCap":18507630},{"date":"2025-02-21","current":-2.42188,"twenty":-4.923399,"median":-2.645943,"eighty":-2.049178,"marketCap":22680335},{"date":"2025-02-28","current":-2.238151,"twenty":-4.869408,"median":-2.636832,"eighty":-2.049178,"marketCap":20959758},{"date":"2025-03-07","current":-2.204746,"twenty":-4.859238,"median":-2.619088,"eighty":-2.043766,"marketCap":20646926},{"date":"2025-03-14","current":-2.021017,"twenty":-4.814317,"median":-2.611175,"eighty":-2.043766,"marketCap":18926349},{"date":"2025-03-21","current":-2.204746,"twenty":-4.762681,"median":-2.603257,"eighty":-2.043766,"marketCap":20646926},{"date":"2025-03-28","current":-2.021017,"twenty":-4.736,"median":-2.593961,"eighty":-2.037721,"marketCap":18926349},{"date":"2025-04-04","current":-1.904099,"twenty":-4.695977,"median":-2.574477,"eighty":-2.024878,"marketCap":17831436},{"date":"2025-04-11","current":-1.78718,"twenty":-4.601221,"median":-2.559576,"eighty":-2.021017,"marketCap":16736523},{"date":"2025-04-17","current":-2.338367,"twenty":-4.561033,"median":-2.554258,"eighty":-2.021017,"marketCap":21898255},{"date":"2025-04-25","current":-2.254854,"twenty":-4.395718,"median":-2.539152,"eighty":-2.021017,"marketCap":21116174},{"date":"2025-05-02","current":-2.221448,"twenty":-4.236599,"median":-2.517715,"eighty":-2.021017,"marketCap":20803342},{"date":"2025-05-09","current":-2.355069,"twenty":-4.022387,"median":-2.509122,"eighty":-2.021017,"marketCap":22054671},{"date":"2025-05-16","current":-2.188043,"twenty":-3.94774,"median":-2.501973,"eighty":-2.021017,"marketCap":20490510},{"date":"2025-05-23","current":-2.379913,"twenty":-3.876119,"median":-2.498632,"eighty":-2.021017,"marketCap":23149584},{"date":"2025-05-30","current":-2.524637,"twenty":-3.823943,"median":-2.498632,"eighty":-2.021017,"marketCap":24557329},{"date":"2025-06-06","current":-2.395993,"twenty":-3.78622,"median":-2.493989,"eighty":-2.021017,"marketCap":23306000},{"date":"2025-06-13","current":-2.494967,"twenty":-3.754515,"median":-2.493989,"eighty":-2.021017,"marketCap":24268720},{"date":"2025-06-20","current":-2.214076,"twenty":-3.676342,"median":-2.479073,"eighty":-2.020561,"marketCap":21536480},{"date":"2025-06-27","current":-2.032324,"twenty":-3.636238,"median":-2.464048,"eighty":-2.020561,"marketCap":19768560},{"date":"2025-07-03","current":-2.280168,"twenty":-3.554341,"median":-2.459464,"eighty":-2.020561,"marketCap":22179360},{"date":"2025-07-11","current":-2.329737,"twenty":-3.48487,"median":-2.44873,"eighty":-2.020561,"marketCap":22661520},{"date":"2025-07-18","current":-2.709765,"twenty":-3.426034,"median":-2.448382,"eighty":-2.020561,"marketCap":26358080},{"date":"2025-07-25","current":-2.825426,"twenty":-3.389044,"median":-2.448382,"eighty":-2.020561,"marketCap":27483120},{"date":"2025-08-01","current":-2.676719,"twenty":-3.365641,"median":-2.448382,"eighty":-2.020561,"marketCap":26036640},{"date":"2025-08-08","current":-2.610627,"twenty":-3.332199,"median":-2.448382,"eighty":-2.020561,"marketCap":25393760},{"date":"2025-08-15","current":-2.428875,"twenty":-3.310157,"median":-2.445165,"eighty":-2.020561,"marketCap":23625840},{"date":"2025-08-22","current":-2.263645,"twenty":-3.264565,"median":-2.436645,"eighty":-2.020561,"marketCap":22018640},{"date":"2025-08-29","current":-2.337999,"twenty":-3.264565,"median":-2.434612,"eighty":-2.020561,"marketCap":22741880},{"date":"2025-09-05","current":-2.271907,"twenty":-3.248873,"median":-2.421397,"eighty":-2.020104,"marketCap":22099000},{"date":"2025-09-12","current":-2.362783,"twenty":-3.247549,"median":-2.416566,"eighty":-2.020561,"marketCap":22982960},{"date":"2025-09-19","current":-2.34626,"twenty":-3.208752,"median":-2.407158,"eighty":-2.020561,"marketCap":22822240},{"date":"2025-09-26","current":-2.313214,"twenty":-3.208752,"median":-2.402267,"eighty":-2.020561,"marketCap":22500800},{"date":"2025-10-03","current":-2.63298,"twenty":-3.208752,"median":-2.395993,"eighty":-2.020561,"marketCap":24926330},{"date":"2025-10-10","current":-2.623774,"twenty":-3.208752,"median":-2.395993,"eighty":-2.020561,"marketCap":24839175},{"date":"2025-10-17","current":-2.669805,"twenty":-3.208752,"median":-2.395993,"eighty":-2.020561,"marketCap":25274950},{"date":"2025-10-24","current":-2.636294,"twenty":-3.208752,"median":-2.395993,"eighty":-2.020561,"marketCap":24957705},{"date":"2025-10-31","current":-3.130116,"twenty":-3.221382,"median":-2.395993,"eighty":-2.020561,"marketCap":29632700},{"date":"2025-11-07","current":-3.498365,"twenty":-3.252844,"median":-2.395993,"eighty":-2.020561,"marketCap":33118900},{"date":"2025-11-14","current":-2.766604,"twenty":-3.254271,"median":-2.395993,"eighty":-2.020561,"marketCap":26191350},{"date":"2025-11-21","current":-2.960813,"twenty":-3.283821,"median":-2.395993,"eighty":-2.020561,"marketCap":24057240},{"date":"2025-11-28","current":-2.702248,"twenty":-3.283821,"median":-2.395993,"eighty":-2.020561,"marketCap":21956340},{"date":"2025-12-05","current":-2.702248,"twenty":-3.283821,"median":-2.395993,"eighty":-2.020561,"marketCap":21956340},{"date":"2025-12-12","current":-2.879445,"twenty":-3.283821,"median":-2.395993,"eighty":-2.020561,"marketCap":23396100},{"date":"2025-12-19","current":-2.680098,"twenty":-3.283821,"median":-2.395993,"eighty":-2.020561,"marketCap":21776370},{"date":"2025-12-26","current":-2.859745,"twenty":-3.283821,"median":-2.395993,"eighty":-2.020561,"marketCap":23236034},{"date":"2026-01-02","current":-2.715556,"twenty":-3.283821,"median":-2.402326,"eighty":-2.020561,"marketCap":22064469},{"date":"2026-01-09","current":-3.211953,"twenty":-3.28831,"median":-2.407158,"eighty":-2.020561,"marketCap":26097799},{"date":"2026-01-16","current":-2.999592,"twenty":-3.28831,"median":-2.407158,"eighty":-2.020561,"marketCap":24372324},{"date":"2026-01-23","current":-3.052682,"twenty":-3.283821,"median":-2.407158,"eighty":-2.020561,"marketCap":24803693},{"date":"2026-01-30","current":-2.654506,"twenty":-3.264565,"median":-2.407158,"eighty":-2.020561,"marketCap":21568429},{"date":"2026-02-06","current":-2.25633,"twenty":-3.241125,"median":-2.403874,"eighty":-2.020561,"marketCap":18333164},{"date":"2026-02-13","current":-2.468691,"twenty":-3.197605,"median":-2.402326,"eighty":-2.020561,"marketCap":20058638},{"date":"2026-02-20","current":-2.622,"twenty":-3.155149,"median":-2.402326,"eighty":-2.020561,"marketCap":21810950},{"date":"2026-02-27","current":-2.596039,"twenty":-3.145533,"median":-2.402326,"eighty":-2.020561,"marketCap":21595000},{"date":"2026-03-06","current":-2.404711,"twenty":-3.130556,"median":-2.402326,"eighty":-2.020561,"marketCap":20003448},{"date":"2026-03-13","current":-3.011406,"twenty":-3.107518,"median":-2.402326,"eighty":-2.020561,"marketCap":25050200},{"date":"2026-03-20","current":-2.725841,"twenty":-3.085568,"median":-2.402326,"eighty":-2.020561,"marketCap":22674750},{"date":"2026-03-27","current":-2.493496,"twenty":-3.067408,"median":-2.402326,"eighty":-2.020561,"marketCap":20741997},{"date":"2026-04-02","current":-2.478179,"twenty":-3.056859,"median":-2.395993,"eighty":-2.020561,"marketCap":20614587},{"date":"2026-04-10","current":-2.751802,"twenty":-3.045861,"median":-2.395993,"eighty":-2.020561,"marketCap":22890700},{"date":"2026-04-17","current":-3.011406,"twenty":-3.040395,"median":-2.395993,"eighty":-2.020561,"marketCap":25050200},{"date":"2026-04-24","current":-3.374851,"twenty":-3.044156,"median":-2.395993,"eighty":-2.020561,"marketCap":28073500},{"date":"2026-05-01","current":-3.219089,"twenty":-3.045861,"median":-2.395993,"eighty":-2.020561,"marketCap":26777800},{"date":"2026-05-08","current":-3.686376,"twenty":-3.058121,"median":-2.395993,"eighty":-2.020561,"marketCap":30664900},{"date":"2026-05-15","current":-4.517108,"twenty":-3.071528,"median":-2.399427,"eighty":-2.020561,"marketCap":37575300},{"date":"2026-05-22","current":-4.364053,"twenty":-3.071528,"median":-2.399427,"eighty":-2.020561,"marketCap":35309517},{"date":"2026-05-29","current":-5.236864,"twenty":-3.068606,"median":-2.39771,"eighty":-2.020104,"marketCap":42371421},{"date":"2026-06-05","current":-4.223278,"twenty":-3.071528,"median":-2.399427,"eighty":-2.020561,"marketCap":34170501},{"date":"2026-06-12","current":-3.85726,"twenty":-3.071528,"median":-2.399427,"eighty":-2.020561,"marketCap":31209057},{"date":"2026-06-18","current":-3.772795,"twenty":-3.071528,"median":-2.399427,"eighty":-2.020561,"marketCap":30525647},{"date":"2026-06-26","current":-3.660174,"twenty":-3.068606,"median":-2.39771,"eighty":-2.020104,"marketCap":29614434},{"date":"2026-07-02","current":-3.80095,"twenty":-3.068606,"median":-2.39771,"eighty":-2.020104,"marketCap":30753450},{"date":"2026-07-10","current":-4.532985,"twenty":-3.068606,"median":-2.39771,"eighty":-2.020104,"marketCap":36676337},{"date":"2026-07-17","current":-4.983468,"twenty":-3.068606,"median":-2.39771,"eighty":-2.020104,"marketCap":40321191},{"date":"2026-07-24","current":-4.307743,"twenty":-3.068606,"median":-2.39771,"eighty":-2.020104,"marketCap":34853911},{"date":"2026-07-31","current":-4.364053,"twenty":-3.067408,"median":-2.395993,"eighty":-2.019648,"marketCap":35309517},{"date":"2026-08-07","current":-3.941726,"twenty":-3.067408,"median":-2.395993,"eighty":-2.019648,"marketCap":31892467},{"date":"2026-08-14","current":-3.829105,"twenty":-3.067408,"median":-2.395993,"eighty":-2.019648,"marketCap":30981254},{"date":"2026-08-21","current":-3.688329,"twenty":-3.067408,"median":-2.395993,"eighty":-2.019648,"marketCap":29842237},{"date":"2026-08-28","current":-3.603863,"twenty":-3.067408,"median":-2.395993,"eighty":-2.019648,"marketCap":29158827},{"date":"2026-09-04","current":-3.237846,"twenty":-3.067408,"median":-2.395993,"eighty":-2.019648,"marketCap":26197384},{"date":"2026-09-11","current":-2.871829,"twenty":-3.056678,"median":-2.395993,"eighty":-2.019648,"marketCap":23235940},{"date":"2026-09-18","current":-3.941726,"twenty":-3.052682,"median":-2.395993,"eighty":-2.019648,"marketCap":31892467},{"date":"2026-09-25","current":-4.054346,"twenty":-3.052682,"median":-2.395993,"eighty":-2.019648,"marketCap":32803680},{"date":"2026-10-02","current":-3.913301,"twenty":-3.052682,"median":-2.395993,"eighty":-2.019648,"marketCap":32161500},{"date":"2026-10-06","current":-4.503402,"twenty":-3.052682,"median":-2.395993,"eighty":-2.019648,"marketCap":37011250}],"updateTime":1791368518892},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NNVC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673805918","title":"NanoViricides to Present at NIBA 153rd Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2673805918","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673805918?lang=en_us&edition=fundamental","pubTime":"2026-10-06 20:45","pubTimestamp":1791290724,"startTime":"0","endTime":"0","summary":"NanoViricides to present at NIBA 153rd Investment ConferenceNanoViricides will present on Oct. 7, 2026 at NIBA’s 153rd Investment Conference in Fort Lauderdale, Florida.Disclaimer:This news brief was ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDLMpPq7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","NNVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673070387","title":"NanoViricides says Phase II trial of NV-387 in ebola ‘proceeding as designed’","url":"https://stock-news.laohu8.com/highlight/detail?id=2673070387","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673070387?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:50","pubTimestamp":1791204624,"startTime":"0","endTime":"0","summary":"NanoViricides (NNVC) provides additional details on its Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Eb...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanoviricides-says-phase-ii-trial-of-nv-387-in-ebola-proceeding-as-designed-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanoviricides-says-phase-ii-trial-of-nv-387-in-ebola-proceeding-as-designed-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NNVC","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673170745","title":"NanoViricides Begins Phase II Trial of NV-387 Oral Gummies for Bundibugyo Ebola in DRC","url":"https://stock-news.laohu8.com/highlight/detail?id=2673170745","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673170745?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:45","pubTimestamp":1791204346,"startTime":"0","endTime":"0","summary":"NanoViricides begins Phase II trial of NV-387 oral gummies for Bundibugyo Ebola in DRCNanoViricides outlined progress in its Phase II trial of NV-387 oral gummies for Bundibugyo Ebola in the Democrati","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL9Z35Qw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","NNVC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671353247","title":"NanoViricides Sets President Anil Diwan Base Salary at $400,000 Under Extension Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2671353247","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671353247?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:31","pubTimestamp":1790713861,"startTime":"0","endTime":"0","summary":"NanoViricides sets president Anil Diwan base salary at $400,000 under extension agreementNanoViricides extended President Anil R. Diwan’s employment through June 30, 2027, setting an annual base salar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL9r4V3C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNVC","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671126422","title":"NanoViricides ‘actively exploring’ additional required funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2671126422","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671126422?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:56","pubTimestamp":1790686564,"startTime":"0","endTime":"0","summary":"The company said, “We reported that, as of June 30, 2026, we had cash and cash equivalent current assets balance of approximately $2.79M. In additi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanoviricides-actively-exploring-additional-required-funding-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanoviricides-actively-exploring-additional-required-funding-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NNVC","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671126092","title":"NanoViricides reports FY26 EPS (41c) vs. (63c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2671126092","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671126092?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:50","pubTimestamp":1790686213,"startTime":"0","endTime":"0","summary":"The company said, “In the fiscal year 2026, we have achieved a substantial level of accomplishments. We have focused on regulatory advancement of o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanoviricides-reports-fy26-eps-41c-vs-63c-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanoviricides-reports-fy26-eps-41c-vs-63c-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NNVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671268214","title":"Nanoviricides Q4 EPS $(0.10), Inline","url":"https://stock-news.laohu8.com/highlight/detail?id=2671268214","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671268214?lang=en_us&edition=fundamental","pubTime":"2026-09-29 05:47","pubTimestamp":1790632052,"startTime":"0","endTime":"0","summary":"Nanoviricides (AMEX:NNVC) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 23.08 percent increase over losses of $(0.13) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/09/62037224/nanoviricides-q4-eps-0-10-inline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Nanoviricides Q4 EPS $(0.10), Inline","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","NNVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671250558","title":"NanoViricides FY26 Net Loss Narrows 13% to $8.22 Million; Revenue Remains no Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2671250558","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671250558?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:32","pubTimestamp":1790627535,"startTime":"0","endTime":"0","summary":"NanoViricides FY26 net loss narrows 13% to $8.22 million; revenue remains no revenueNanoViricides posted a net loss of $8.22 million for the year ended June 30, 2026, narrowing 13%.Basic and diluted l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL7KM1TX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","NNVC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670237478","title":"NanoViricides Starts Phase II DRC Trial of Oral NV-387 Gummies in Bundibugyo Ebola Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2670237478","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670237478?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:45","pubTimestamp":1790599532,"startTime":"0","endTime":"0","summary":"NanoViricides starts Phase II DRC trial of oral NV-387 gummies in Bundibugyo Ebola patientsNanoViricides began enrolling and dosing patients in a Phase II trial of NV-387 oral gummies for Ebola in the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL2v5BJN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNVC","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669919495","title":"Analysts Offer Insights on Healthcare Companies: NanoViricides (NNVC) and Ionis Pharmaceuticals (IONS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669919495","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669919495?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:30","pubTimestamp":1790256610,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on NanoViricides (NNVC) and Ionis Pharmaceuticals (IONS). NanoVirici...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nanoviricides-nnvc-and-ionis-pharmaceuticals-ions-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nanoviricides-nnvc-and-ionis-pharmaceuticals-ions-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4137","BK4568","LABU","BK4585","XLV","BK4139","IONS","LU0128526141.USD","BK4581","HCSG","XBI","BK4588","NNVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669864854","title":"NanoViricides begins Phase II trial of NV-387 in Monkeypox in DRC","url":"https://stock-news.laohu8.com/highlight/detail?id=2669864854","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669864854?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:55","pubTimestamp":1790168135,"startTime":"0","endTime":"0","summary":"NanoViricides (NNVC) announced that the Phase II Clinical Trial of the Company’s Novel Broad-Spectrum Antiviral Drug NV-387 as a Treatment for Monk...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanoviricides-begins-phase-ii-trial-of-nv-387-in-monkeypox-in-drc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanoviricides-begins-phase-ii-trial-of-nv-387-in-monkeypox-in-drc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4568","NNVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669450485","title":"NanoViricides Begins Phase II Trial of NV-387 Oral Gummies for Mpox in Congo","url":"https://stock-news.laohu8.com/highlight/detail?id=2669450485","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669450485?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:32","pubTimestamp":1790166736,"startTime":"0","endTime":"0","summary":"NanoViricides begins Phase II trial of NV-387 oral gummies for mpox in CongoNanoViricides began a Phase II trial of NV-387 oral gummies for mpox, enrolling the first patients in the Democratic Republi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDLbFXhrZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","NNVC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378562","title":"NanoViricides Wins DRC Regulatory Clearance to Start Phase II NV-387 Ebola Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378562","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378562?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:30","pubTimestamp":1788870648,"startTime":"0","endTime":"0","summary":"NanoViricides wins DRC regulatory clearance to start Phase II NV-387 Ebola trialNanoViricides secured DRC regulatory clearance to start a Phase II trial of its NV-387 oral gummies for Bundibugyo Ebola","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLHzFbP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNVC","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663500530","title":"NanoViricides provides updateon Measles Drug Treatment Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2663500530","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663500530?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:45","pubTimestamp":1788180332,"startTime":"0","endTime":"0","summary":"The company said, “While CDC is reviewing the two recent measles-related fatalities in Pennsylvania, the total number of confirmed measles cases in...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanoviricides-provides-updateon-measles-drug-treatment-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanoviricides-provides-updateon-measles-drug-treatment-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4139","NNVC","CDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663003610","title":"NanoViricides Drafts Phase II Trial Protocol for NV-387 Measles Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2663003610","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663003610?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:31","pubTimestamp":1788179503,"startTime":"0","endTime":"0","summary":"NanoViricides drafts Phase II trial protocol for NV-387 measles treatmentNanoViricides moved toward a Phase II trial of NV-387 to treat measles, with a draft protocol now in circulation.Clinical resul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL2RQYSm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNVC","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661629068","title":"NanoViricides registers to sell 2.52M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2661629068","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661629068?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:35","pubTimestamp":1787344514,"startTime":"0","endTime":"0","summary":"This filing relates to the offer and sale from time to time by the selling stockholders of up to 2.52M shares of common stock. The company is not s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanoviricides-registers-to-sell-2-52m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanoviricides-registers-to-sell-2-52m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NNVC","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660467984","title":"NanoViricides to begin Phase II trial of NV-387 in ebola ‘soon’","url":"https://stock-news.laohu8.com/highlight/detail?id=2660467984","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660467984?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:40","pubTimestamp":1787056810,"startTime":"0","endTime":"0","summary":"NanoViricides (NNVC), announced that the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus and ot...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanoviricides-to-begin-phase-ii-trial-of-nv-387-in-ebola-soon-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanoviricides-to-begin-phase-ii-trial-of-nv-387-in-ebola-soon-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4139","NNVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660620944","title":"NanoViricides Wins DRC Acorep Clearance for Phase II NV-387 Ebola Treatment Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2660620944","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660620944?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:30","pubTimestamp":1787056240,"startTime":"0","endTime":"0","summary":"NanoViricides wins DRC ACOREP clearance for Phase II NV-387 Ebola treatment trialNanoViricides secured clearance from DRC regulator ACOREP to start a Phase II trial of NV-387 oral gummies for Bundibug","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL2z8SMr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNVC","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658360599","title":"NanoViricides, Inc: Received Regulatory Approval for a Phase Ii Clinical Trial of Nv-387 Oral Gummies as a Treatment for Ebola in DR Congo","url":"https://stock-news.laohu8.com/highlight/detail?id=2658360599","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658360599?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:31","pubTimestamp":1786365105,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4470NZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NNVC","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658936014","title":"NanoViricides Wins DRC Approval for Phase II Trial of NV-387 Oral Gummies for Ebola Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2658936014","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658936014?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:31","pubTimestamp":1786365085,"startTime":"0","endTime":"0","summary":"NanoViricides wins DRC approval for Phase II trial of NV-387 oral gummies for Ebola treatmentNanoViricides won ACOREP clearance in DR Congo to launch a Phase II trial of NV-387 oral gummies for Bundib","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDLccfVb3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNVC","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":60,"code":"91000000","status":"200"}]}}